Page 31 - M. Immunology
P. 31

TAM Family of Receptor Tyrosine Kinases: roles in anti-inflammation
                               through regulating Macrophage Function
                                      In-Byung Park and Taehoon Chun
                      Department of Biotechnology, Major in Molecular Bioengineering,
                         Korea University Graduate School, Seoul, Republic of Korea


                                  BACKGROUND                                                  AIM
    ⚫ Macrophage is a key mediator of innate immunity which controls initial inflammation and immune homeostasis (Mosser and   ⚫ We will focus on
    Edwards, 2008). Macrophage are classified as m1 or M2 phenotype depending on which stimulus they are first exposed to within a   mechanisms how TAM
    certain microenvironment (Mills et al., 2000).                                     receptor signaling inhibits
    ⚫ Receptor tyrosine kinases (RTKs) are essential membrane proteins that transmit extracellular signal through phosphorylation of   inflammatory responses via
    tyrosine residue within their cytoplasmic domains (Robinson et al., 2000). Among 20 subfamilies of RTKs, TAM receptor family   manipulation of macrophage
    consisting of Tyro3, Axl, and Mer is the main family that gives a pleiotropic anti-inflammatory response.  phenotype.
                                                 RESULTS
                                                                    Fig. 1. Structures of TAM family receptors and their
                                                                    ligands.
                                                                    Ig superfamily domains of each TAM receptor recognize their
                                                                    ligands. The extracellular domain of each TAM family receptor
                                                                    contains two Ig superfamily domains and two fibronectin type
                                                                    Ⅲ domains. The cytoplasmic domain of each TAM family
                                                                    receptor contains a conserved protein tyrosine kinase (PTK)
                                                                    domain and immunoreceptor tyrosine based inhibitory motif
                                                                    (ITIM) domain. Autophosphorylation sites of each TAM family
                                                                    receptor are located within PTK domain. In addition, the
                                                                    cytoplasmic domain of each TAM family receptor includes
                                                                    well-conserved “KW(I/L)A(I/L)ES” signature sequence.
                                                                    Gas6 can bind to all three TAM family receptors with the
                                                                    highest affinity to Axl, whereas Pros1 can interact with Mer or
                                                                    Tyro3, but not Axl. Gas6 and Pros1 have γ-carboxyglutamate-
                                                                    rich domain (Gla domain) at their amino terminus. Additionally,
                                                                    the proteins contain four epidermal growth factor (EGF)-like
                                                                    domains and one sex hormone binding globulin (SHBG)
                                                                    domain which consists of two globular laminin G-like (LG)
                                                                    domain.



















    Fig. 2. Pleotropic inhibition of inflammatory responses by TAM family receptors expressed on macrophages.
    (A) TAM receptor signaling enhances phagocytosis of apoptotic cells.
    (B) Attenuation of type I IFN-mediated inflammatory responses by TAM receptor signaling.
    (C) TAM receptor signaling suppresses NLRP3 inflammasome activation by autophage induction.
    (D) TAM receptor signaling inhibits M1 macrophage polarization and enhances M2 macrophage polarization by induction of IL-10.

                       CONCLUSION                                           REFERENCES
    ⚫ As an immune modulator, macrophage is a powerful governor that initiates or block   Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J., and Hill, A.M.
    inflammatory responses by manipulating activities of other immune cell population. Therefore,   (2000). M-1/M-2 macrophages and the Th1/Th2 paradigm.
    finding new key molecule that can regulate the activity of macrophage may be a beneficial   J.Immunol. 164, 6166-6173.
    strategy to design novel immunotherapy.                     Mosser, D.M., and Edwards, J.P. (2008). Exploring the full
    ⚫ Numerous observations have suggested that TAM family receptor expressed on   spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
    macrophage can act as a powerful inhibitor against a broad range of inflammatory response.  Robinson, D.R., Wu, Y.M., and Lin, S.F. (2000). The protein
    ⚫ Enhancement of TAM receptor signaling may be one option to suppress inflammatory   tyrosine kinase family of the human genome. Oncogene 19, 5548-
    diseases such as graft rejection and autoimmune disease. In contrast, inhibition of TAM   5557.
    receptor signaling may be necessary for successful anti-cancer therapy or applied to new   Zhang, L., DeBerge, M., Wang, J., Dangi, A., Zhang, X., Schroth,
    regiment to treat M2-prone allergic responses. Indeed, several examples have already shown   S., Zhang, Z., Thorp, E.B., and Luo, X. (2018). Receptor tyrosine
    the possibility of TAM receptor signaling as a new drug target. For example, TAM receptor   kinase MerTK suppresses an allogenic type I IFN response to
    signaling inhibits an allogenic type I IFN response in murine islet or heart transplant model   promote transplant tolerance. Am. J. Transplant. [In press] Available
    (Zhang et al., 2018).                                       at: https://doi.org/10.1111/ajt.15087
                ACKNOWLEDGEMENTS                                    CONTACT INFORMATION
    ⚫ This work was supported by a grant from the Next-Generation BioGreen 21 Program   E-mail address: tnquddls@korea.ac.kr
    (Project No. PJ01327101), Rural Development Administration, Republic of Korea.  Address: Life science West Building, Korea University, Seongbuk-
                                                                gu, Anam-ro 145, Seoul
   26   27   28   29   30   31   32   33   34   35   36